Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+18.82%
adds when stocks drop
when a holding falls −10%+
Middle response
+10.61%
steady accumulation
Rally response
-4.77%
trims into rallies
when a holding rises +10%+
Top positions · 14
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | $63M | 19.0% | +174.5% | 2.5 yr |
| VECOVeeco Instruments Inc. | $34M | 10.2% | +68.6% | 0.3 yr |
| PRVAPrivia Health Group, Inc | $33M | 9.8% | -8.4% | 2.5 yr |
| DHCDiversified Healthcare T | $32M | 9.6% | +180.2% | 2.5 yr |
| NEENextEra Energy, Inc. | $31M | 9.4% | +34.9% | 1.0 yr |
| MHMcGraw Hill, Inc. | $29M | 8.6% | — | 0.8 yr |
| — | $24M | 7.1% | — | 0.5 yr |
| AMRXAmneal Pharmaceuticals, | $21M | 6.2% | +48.3% | 2.3 yr |
| VKTXViking Therapeutics, Inc | $20M | 6.1% | +34.7% | 1.0 yr |
| NXPINXP Semiconductors N.V. | $12M | 3.6% | +5.0% | 0.3 yr |
| ABUSArbutus Biopharma Corpor | $11M | 3.4% | +28.9% | 2.3 yr |
| GBTGGlobal Business Travel G | $11M | 3.4% | -23.1% | 0.3 yr |
| CCOICogent Communications Ho | $9M | 2.8% | -67.6% | 1.3 yr |
| SEATVivid Seats Inc. | $3M | 0.9% | — | 0.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology28.5%+9.4pp$95M
Semiconductors13.7%+5.6pp$46M
Medical - Healthcare Information Services9.8%+4.1pp$33M
REIT - Healthcare Facilities9.6%+4.5pp$32M
Regulated Electric9.4%$31M
Education & Training Services8.6%$29M
Unknown7.1%+4.6pp$24M
Drug Manufacturers - Specialty & Generic6.2%-7.6pp$21M
Software - Application3.4%$11M
Telecommunications Services2.8%-1.1pp$9M
Country
US70.3%-5.3pp
GB19.0%+2.7pp
Unknown7.1%+4.6pp
NL3.6%
Top 5: 58.0% · Top 10: 89.5% · Top 25: 100.0%
Top buys this quarter · 10
| VECO Veeco Instruments Inc.new | +$34M |
| NXPI NXP Semiconductors N.V.new | +$12M |
| GBTG Global Business Travel Group, new | +$11M |
| MH McGraw Hill, Inc. | +$9M |
| PRVA Privia Health Group, Inc. | +$6M |
| SEAT Vivid Seats Inc.new | +$3M |
| ABUS Arbutus Biopharma Corporation | +$3M |
| VKTX Viking Therapeutics, Inc. | +$2M |
| AMRX Amneal Pharmaceuticals, Inc. | +$1M |
| — | +$24M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $332M | 14 | +53.07% | +17.59% | +35.48% | +0.03B |
| 2025-12-31 | $279M | 11 | +36.41% | +17.72% | +18.69% | -0.07B |
| 2025-09-30 | $306M | 15 | +12.55% | +17.52% | -4.96% | -0.05B |
| 2025-06-30 | $302M | 20 | +8.37% | +14.94% | -6.57% | -0.01B |
| 2025-03-31 | $293M | 18 | -0.91% | +8.30% | -9.21% | +0.05B |
| 2024-12-31 | $254M | 15 | +9.89% | +24.89% | -15.00% | +0.04B |
| 2024-09-30 | $230M | 18 | +13.18% | +5.75% | +7.43% | +0.01B |
| 2024-06-30 | $194M | 17 | -3.77% | +4.38% | -8.15% | +0.03B |
| 2024-03-31 | $173M | 21 | +6.92% | +10.39% | -3.47% | +0.01B |
| 2023-12-31 | $151M | 17 | — | — | — | — |